Motif Bio PLC Conversion of CPNs, PDMR Dealing & TVR (5423S)

TIDMMTFB

RNS Number : 5423S

Motif Bio PLC

21 December 2016

This announcement contains inside information

Motif Bio plc

("Motif Bio" or the "Company")

Conversion of Convertible Promissory Notes, PDMR Dealing and Total Voting Rights

Motif Bio plc (AIM: MTFB) the clinical stage biopharmaceutical company specialising in developing novel antibiotics announces, that it has issued, in aggregate, 14,510,770 new ordinary shares in the Company ("Ordinary Shares") following the conversion by Amphion Innovations plc and Amphion Innovations US Inc., (the "Amphion Parties") of the Convertible Promissory Notes ("CPNs"). The CPNs which totalled US$3,550,786 were converted in accordance with their terms at US$0.2447 per share.

Following the conversion, the Amphion Parties will hold no further CPNs and their holding will total 43,240,645 ordinary shares being 22 per cent. of the Company.

Richard Morgan and Robert Bertoldi, Non-Executive Chairman and Executive Director of the Company respectively, are also directors of Amphion Innovations plc (the "Amphion Directors"). Amphion Innovations plc is therefore a "Person Closely Associated" with the Amphion Directors under the Market Abuse Regulation.

Application has been made for the 14,510,770 new Ordinary Shares to be admitted to trading on AIM ("Admission"), which is expected to occur at 8.00 a.m. on 29 December 2016. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares. Following Admission, and for the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital will consist of 195,741,528 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company.

For further information, please contact:

 
 Motif Bio plc                          [e-mail] 
 Graham Lumsden (Chief 
  Executive Officer) 
 
 Zeus Capital Limited 
  (NOMAD & BROKER)                    [phone] 
 Phil Walker/Giles Balleny 
 Dominic Wilson 
 
 Northland Capital Partners 
  Limited (BROKER)                    [phone] 
 Patrick Claridge/ David 
  Hignell 
 John Howes/ Rob Rees 
  (Broking) 
 
 Walbrook PR Ltd. (FINANCIAL      [phone] or 
  PR & IR)                        [e-mail] 
 Paul McManus                        Mob: [phone] 
                                                      893 
 Mike Wort                           Mob: [phone] 
                                                      002 
 
 MC Services AG (EUROPEAN 
  IR)                                  [phone] 
 Raimund Gabriel 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

 
 
 1       Details of the person discharging managerial responsibilities/person closely associated 
------  ----------------------------------------------------------------------------------------------- 
 a)      Name                                          Amphion Innovations Plc 
------  --------------------------------------------  ------------------------------------------------- 
 2       Reason for the notification 
------  ----------------------------------------------------------------------------------------------- 
                                                       Person Closely Associated with 
 a)       Position/status                               PDMRs of Motif Bio Plc (Robert 
                                                        Bertoldi and Richard Morgan) 
------  --------------------------------------------  ------------------------------------------------- 
 b)      Initial notification/Amendment                Initial Notification 
------  --------------------------------------------  ------------------------------------------------- 
 3       Details of the issuer, emission allowance market participant, auction platform, auctioneer 
          or auction monitor 
------  ----------------------------------------------------------------------------------------------- 
 a)      Name                                          Motif Bio Plc 
------  --------------------------------------------  ------------------------------------------------- 
 b)      LEI                                           N/A 
------  --------------------------------------------  ------------------------------------------------- 
 4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; and (iv) each place where transactions have been 
          conducted 
------  ----------------------------------------------------------------------------------------------- 
 a)      Description of the                            Ordinary Shares 
          financial instrument, 
          type of instrument                            ISIN GB00BVVT4H71 
 
          Identification code 
------  --------------------------------------------  ------------------------------------------------- 
 b)      Nature of the transaction                     Exercise of Convertible Promissory 
                                                        Notes into 14,510,770 Ordinary 
                                                        Shares 
------  --------------------------------------------  ------------------------------------------------- 
 c)      Price(s) and volume(s)                         Price(s)    Volume(s) 
                                                        ----------  ----------- 
                                                         N/A         14,510,770 
                                                        ----------  ----------- 
------  --------------------------------------------  ------------------------------------------------- 
 d)      Aggregated information                         Price(s)    Volume(s) 
                                                        ----------  ----------- 
                                                         N/A         14,510,770 
                                                        ----------  ----------- 
------  --------------------------------------------  ------------------------------------------------- 
 e)      Date of the transaction                       21December 2016 
------  --------------------------------------------  ------------------------------------------------- 
 f)      Place of the transaction                      N/A 
------  --------------------------------------------  ------------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUASBRNWAUUAA

(END) Dow Jones Newswires

December 21, 2016 12:50 ET (17:50 GMT)